Filing Flows › Precision Biosciences (DTIL) › Q3 FY26 › vs Q2 FY26
Precision Biosciences (DTIL) Q3 FY26 vs Q2 FY26 (quarter over quarter)
Precision Biosciences's revenue fell $23.4M (-68%) from $34.2M in Q2 FY26 to $10.8M in Q3 FY26.
Precision Biosciences, Q3 FY26: revenue $10.8M (374× year over year), operating margin -83.7%, net loss $18.4M, operating cash flow −$11.9M. The chart draws each line against Q2 FY26, the increases inside each band.
Every line
| Line | Q3 FY26 | Q2 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $10.8M | $34.2M | −$23.4M | -68% |
| Net loss | $18.4M | −$20.1M | $38.6M | — |
| Costs & expenses | $29.3M | $41.8M | −$12.6M | -30% |
| Operating costs | $19.9M | $21.7M | −$1.8M | -8% |
| Interest & other, net | $9.4M | −$7.6M | $17.0M | — |
| Research & development | $13.1M | $14.5M | −$1.4M | -9% |
| General & admin | $6.8M | $7.2M | −$429K | -6% |
| Operating cash sources | $18.4M | −$20.1M | $38.6M | — |
| Depreciation & amortization | $299K | $345K | −$46K | -13% |
| Share-based compensation | $1.5M | $2.0M | −$492K | -24% |
| Working capital & other | $4.7M | −$33.8M | $38.4M | — |
| Cash used in operations | $11.9M | $11.2M | $687K | +6% |
| Net loss absorbed | $18.4M | −$20.1M | $38.6M | — |
Questions
How much did Precision Biosciences's revenue grow quarter over quarter in Q3 FY26?
Precision Biosciences's revenue fell $23.4M (-68%) from $34.2M in Q2 FY26 to $10.8M in Q3 FY26.